gadolinium has been researched along with Uremia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aarabi, M; Akbarian, F; Boroumand, B; Memon, KK; Shafiee, MA | 1 |
Pratt, RD; Smyth, MD | 1 |
Almén, T; Elmståhl, B; Golman, K; Leander, P; Nilsson, M; Nyman, U | 1 |
Ailawadi, G; Dimick, JB; Henke, PK; Stanley, JC; Upchurch, GR; Williams, DM | 1 |
Bader, BD; Berger, ED; Duda, S; Erley, CM; Risler, T; Tepe, G; Tuncel, N; Winkler, S | 1 |
Aime, S; Canavese, C; Stratta, P | 1 |
1 review(s) available for gadolinium and Uremia
Article | Year |
---|---|
Dermatologic Manifestations in End-stage Renal Disease.
Topics: Calcinosis; Calciphylaxis; Gadolinium; Humans; Kidney Failure, Chronic; Nail Diseases; Nephrogenic Fibrosing Dermopathy; Pigmentation Disorders; Pruritus; Skin Diseases; Skin Diseases, Vesiculobullous; Uremia | 2015 |
2 trial(s) available for gadolinium and Uremia
Article | Year |
---|---|
Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Catheterization; Contrast Media; Female; Gadolinium; Humans; Male; Middle Aged; Renal Artery; Renal Artery Obstruction; Renal Circulation; Sensitivity and Specificity; Uremia | 2003 |
Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients.
Topics: Aged; Angiography, Digital Subtraction; Aortic Aneurysm; Contrast Media; Double-Blind Method; Female; Gadolinium; Glomerular Filtration Rate; Humans; Iohexol; Male; Middle Aged; Organometallic Compounds; Pilot Projects; Renal Artery Obstruction; Renal Insufficiency; Severity of Illness Index; Uremia; Vascular Diseases | 2004 |
3 other study(ies) available for gadolinium and Uremia
Article | Year |
---|---|
Letter regarding 'Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate'.
Topics: Chelating Agents; Contraindications; Contrast Media; Gadolinium; Humans; Kidney Diseases; Kidney Failure, Chronic; Lanthanum; United States; United States Food and Drug Administration; Uremia | 2008 |
Gadolinium contrast media for DSA in azotemia: are they really safer than iodinated agents?
Topics: Angiography, Digital Subtraction; Animals; Contrast Media; Gadolinium; Humans; Iodine; Kidney Diseases; Mice; Osmolar Concentration; Rats; Uremia | 2002 |
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate.
Topics: Chelating Agents; Contraindications; Fibrosis; Gadolinium; Humans; Kidney Diseases; Kidney Failure, Chronic; Lanthanum; Skin Diseases; United States; United States Food and Drug Administration; Uremia | 2007 |